跳至主要内容
临床试验/ACTRN12618001751268
ACTRN12618001751268尚未招募未知

Meaning and Purpose (MaP) Therapy in Advanced Cancer Patients: A Randomised Controlled Trial targeting psychological wellbeing

niversity of Notre Dame Australia0 个研究点目标入组 300 人开始时间: 2018年10月24日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • aged 18 years or older; No upper age limit
  • advanced cancer with a prognosis of 2 years or less;
  • Distress Thermometer score greater tan or equal to 4
  • fluent in spoken and written English; and
  • ability to give written informed consent
  • willingness to participate in and comply with the study.

排除标准

  • known cognitive impairment that would interfere with participation;
  • too unwell or frail (e.g., impairment associated with co-morbid conditions) to participate as determined by treating clinicians.

研究者

发起方
niversity of Notre Dame Australia

相似试验